Potential use of polyamidoamine dendrimer/α-cyclodextrin conjugate (generation 3, G3) as a novel carrier for short hairpin RNA-expressing plasmid DNA

Journal of Pharmaceutical Sciences

Volumn 97, Issue 8, 2008, Pages 3022-3034

  Tsutsumi, Toshihito ^a   Hirayama, Fumitoshi ^b   Uekama, Kaneto ^b   Arima, Hidetoshi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b SOJO UNIVERSITY   (Japan)

Author keywords

Conjugation; Cyclodextrins; Dendrimers; DNA oligonucleotide delivery; Polymeric drug carrier

Indexed keywords

ALPHA CYCLODEXTRIN; DENDRIMER; DEOXYRIBONUCLEASE I; DRUG CARRIER; FIREFLY LUCIFERASE; PLASMID DNA; POLYAMIDOAMINE; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CELL VIABILITY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CYTOTOXICITY; DRUG CONJUGATION; DRUG EFFECT; DRUG FORMULATION; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME DEGRADATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PARTICLE SIZE; RNA INTERFERENCE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 52449097964     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21206     Document Type: Article

References (38)

1. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. 1998. Potent and specific genetic interference by double-stranded RNA in Caenor-habditis elegans. Nature 391:806-811.
2. Tuschl T. 2001. RNA interference and small interfering RNAs. Chembiochem 2:239-245.
3. Alisky JM, Davidson BL. 2004. Towards therapy using RNA interference. Am J Pharmacogenomics 4:45-51.
4. McManus MT, Sharp PA. 2002. Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 3:737-747.
5. Zender L, Kubicka S. 2007. Suppression of apoptosis in the liver by systemic and local delivery of small-interfering RNAs. Methods Mol Biol 361:217-226.
6. Thomas M, Klibanov AM. 2003. Non-viral gene therapy: Polycation-mediated DNA delivery. Appl Microbiol Biotechnol 62:27-34.
7. Arima H, Kihara F, Hirayama F, Uekama K. 2001. Enhancement of gene expression by polyamidoamine dendrimer conjugates with α-, β-, and γ-cyclodextrins. Bioconjug Chem 12:476-484.
8. Kihara F, Arima H, Tsutsumi T, Hirayama F, Uekama K. 2002. Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with α-cyclodextrin. Bioconjug Chem 13:1211-1219.
9. Kihara F, Arima H, Tsutsumi T, Hirayama F, Uekama K. 2003. In vitro and in vivo gene transfer by an optimized α-cyclodextrin conjugate with poly-amidoamine dendrimer. Bioconjug Chem 14:342-350.
10. Hamasaki K, Kogure K, Ohwada K. 1996. A biological method for the quantitative measurement of tetrodotoxin (TTX): Tissue culture bioassay in combination with a water-soluble tetrazolium salt. Toxicon 34:490-495.
11. Ishiyama M, Tominaga H, Shiga M, Sasamoto K, Ohkura Y, Ueno K. 1996. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull 19:1518-1520.
12. Braun CS, Jas GS, Choosakoonkriang S, Koe GS, Smith JG, Middaugh CR. 2003. The structure of DNA within cationic lipid/DNA complexes. Biophys J 84:1114-1123.
13. Zhou Y, Li Y. 2004. Studies of interaction between poly(allylamine hydrochloride) and double helix DNA by spectral methods. Biophys Chem 107:273-281.
14. WeiskopfM, Li HJ. 1977. Poly(L-lysine)-DNA interactions in NaCl solutions: B to C and B to psi transitions. Biopolymers 16:669-684.
15. Bello-Roufai M, Lambert O, Pitard B. 2007. Relationships between the physicochemical properties of an amphiphilic triblock copolymers/DNA complexes and their intramuscular transfection efficiency. Nucleic Acids Res 35:728-739.
16. Braun CS, Vetro JA, Tomalia DA, Koe GS, Koe JG, Middaugh CR. 2005. Structure/function relationships of polyamidoamine/DNA dendrimers as gene delivery vehicles. J Pharm Sci 94:423-436.
17. van de Wetering P, Moret EE, Schuurmans-Nieuwenbroek NM, van Steenbergen MJ, Hennink WE. 1999. Structure-activity relationships of water-soluble cationic methacrylate/methacrylamide polymers for nonviral gene delivery. Bioconjug Chem 10:589-597.
18. Wagner E, CottenM, Foisner R, Birnstiel ML. 1991. Transferrin-polycation- DNA complexes: The effect of polycations on the structure of the complex and DNA delivery to cells. Proc Natl Acad Sci USA 88:4255-4259.
19. Cherng JY, van de Wetering P, Talsma H, Crommelin DJ, Hennink WE. 1996. Effect of size and serum proteins on transfection efficiency of poly((2-dimethylamino)ethyl methacrylate)-plasmid nanoparticles. Pharm Res 13:1038-1042.
20. Kunath K, von Harpe A, Fischer D, Petersen H, Bickel U, Voigt K, Kissel T. 2003. Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: Comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. J Control Release 89:113-125.
21. Mislick KA, Baldeschwieler JD. 1996. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc Natl Acad Sci USA 93:12349-12354.
22. Schwartz B, Ivanov MA, Pitard B, Escriou V, Rangara R, Byk G, Wils P, Crouzet J, Scherman D. 1999. Synthetic DNA-compacting peptides derived from human sequence enhance cationic lipid-mediated gene transfer in vitro and in vivo. Gene Ther 6:282-292.
23. Thomas M, Klibanov AM. 2002. Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. Proc Natl Acad Sci USA 99:14640-14645.
24. Wiethoff CM, Gill ML, Koe GS, Koe JG, Middaugh CR. 2003. A fluorescence study of the structure and accessibility of plasmid DNA condensed with cationic gene delivery vehicles. J Pharm Sci 92:1272-1285.
25. Li Z, Zhao R, Wu X, Sun Y, Yao M, Li J, Xu Y, Gu J. 2005. Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics. FASEB J 19: 1978-1985.
26. Avall-Lundqvist E, Economidou-Karaoglou A, Sjovall K, Lans M, Taper HS, Roberfroid M, Eneroth P. 1989. Serum alkaline DNase activity in normal or nonhospitalised individuals. Clin Chim Acta 185:35-43.
27. Abdelhady HG, Allen S, Davies MC, Roberts CJ, Tendler SJ, Williams PM. 2003. Direct real-time molecular scale visualisation of the degradation of condensed DNA complexes exposed to DNase I. Nucleic Acids Res 31:4001-4005.
28. Zhang Z, Huang W, Tang J, Wang E, Dong S. 2002. Conformational transition of DNA induced by cationic lipid vesicle in acidic solution: Spectroscopy investigation. Biophys Chem 97:7-16.
29. Gebhart CL, Kabanov AV. 2001. Evaluation of polyplexes as gene transfer agents. J Control Release 73:401-416.
30. Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T. 2001. Functional anatomy of siRNAs for mediating efficient RNAi in Droso-phila melanogaster embryo lysate. EMBO J 20: 6877-6888.
31. Jenke AC, Scinteie MF, Stehle IM, Lipps HJ. 2004. Expression of a transgene encoded on a non-viral episomal vector is not subject to epigenetic silencing by cytosine methylation. Mol Biol Rep 31:85-90.
32. Nan X, Hyndman L, Agbi N, Porteous DJ, Boyd AC. 2004. Potent stimulation of gene expression by histone deacetylase inhibitors on transiently transfected DNA. Biochem Biophys Res Commun 324:348-354.
33. Arima H, Chihara Y, Arizono M, Yamashita S, Wada K, Hirayama F, Uekama K. 2006. Enhancement of gene transfer activity mediated by mannosylated dendrimer/α-cyclodextrin conjugate (generation 3, G3). J Control Release 116:64-74.
34. Liu J, Valencia-Sanchez MA, Hannon GJ, Parker R. 2005. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol 7:719-723.
35. Sen GL, Blau HM. 2005. Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies. Nat Cell Biol 7:633-636.
36. Sledz CA, Williams BR. 2004. RNA interference and double-stranded-RNA- activated pathways. Biochem Soc Trans 32:952-956.
37. Tsutsumi T, Hirayama F, Uekama K, Arima H. 2007. Evaluation of dendrimer/α-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA). J Control Release 119:349-359.
38. Wada K, Arima H, Tsutsumi T, Chihara Y, Hattori K, Hirayama F, Uekama K. 2005. Improvement of gene delivery mediated by mannosylated dendrimer/α- cyclodextrin conjugates. J Control Release 104:397-413.